Greg Deener

CEO
iCell Gene Therapeutics Inc.

Greg Deener is CEO of iCell Gene Therapeutics

Poster(s):

• W161 - Immune Reset in B Cell Mediated Autoimmune Diseases Using BCMA-CD19 Compound CAR (cCAR) in an Open Label Phase I Clinical Trial
  Wednesday, June 21, 2023

  7:30 AM – 7:30 PM